biotech · Colorectal Cancer · Psoriatic Arthritis, Rheumatoid Arthritis · CRDF
Cardiff Oncology
Cardiff Oncology clinical programs — 58 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 11055 Flintkote Avenue, San Diego, California 92121, US
- Founded
- 1999
- Employees
- 51
- Programs
- 58
- Drugs
- 62
- Patents
- 69
Cardiff Oncology projects
58 ClinicalTrials.gov programs sponsored by Cardiff Oncology.
Cardiff Oncology has 58 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Pharmacokinetic based dosage change
Cardiff Oncology
Severe Haemophilia A
1 trial -
Synacthen (Tetracosactrin)
Cardiff Oncology
Healthy
1 trial -
ketamine
Cardiff Oncology
Healthy Volunteers
1 trial -
Aspirin
Cardiff Oncology
Platelet Dysfunction Due to Aspirin
1 trial -
Fertility Health Screening
Cardiff Oncology
Fertility Awareness
1 trial -
MRI head
Cardiff Oncology
Cystic Fibrosis
1 trial -
OCT
Cardiff Oncology
AMD
1 trial -
Oral Stimulant Drink
Cardiff Oncology
Volatile Organic Compounds
1 trial -
PET imaging
Cardiff Oncology
Pituitary Adenoma
1 trial -
Urodynamics
Cardiff Oncology
Lower Urinary Tract Symptoms
1 trial
Frequently asked questions
How many clinical projects does Cardiff Oncology have?
58 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.